文献速递脑血管病

美国心脏干预后急性缺血性卒中的血管内治疗

Endovascular Treatment of Acute Ischemic Stroke After Cardiac Interventions in the United States.
PubMed 文献 · JAMA Neurol · 2024-01-01

该回顾性队列研究利用2016-2020年美国国家住院样本数据库中4888家医院的数据,分析634407例缺血性卒中住院患者。心脏干预患者接受血管内治疗(EVT)的几率显著低于无心脏干预者(aOR 0.27,95%CI 0.23-0.31),但心脏干预后接受EVT与出院回家几率升高相关(aOR 2.21,95%CI 1.14-4.29)。

要点

  • 心脏干预患者EVT执行率1.6%,显著低于无心脏干预者的3.8%(P<.001)。
  • 调整混杂因素后,心脏干预患者接受EVT的几率更低(aOR 0.27,95%CI 0.23-0.31)。
  • 心脏干预后接受EVT与出院回家几率升高相关(aOR 2.21,95%CI 1.14-4.29)。

核心结论

  • 住院缺血性卒中合并心脏干预的患者接受EVT的几率可能不到无心脏干预者的一半。
  • 鉴于EVT的已知获益,需要更好地理解该人群EVT率较低的原因。

研究设计与样本

  • 回顾性队列研究,使用2016-2020年美国国家住院样本数据库中4888家美国医院的数据。
  • 纳入年龄≥18岁的缺血性卒中成人住院患者,分为有心脏干预组和无心脏干预组。
  • 排除入院前已接受任一操作、心脏干预前已行EVT、入院或心脏干预后超过3天行EVT、或心内膜炎的患者。
  • 数据分析时间为2023年4月至2023年10月。

主要发现

  • 共634407例住院,患者平均(SD)年龄69.8(14.1)岁,男性318363例(50.2%),女性316044例(49.8%)。
  • 12093例有心脏干预;218576例记录了NIHSS评分,其中心脏干预组2541例(21.0%),无心脏干预组216035例(34.7%)(P<.001)。
  • 无心脏干预组23660例(3.8%)接受EVT,心脏干预组194例(1.6%)接受EVT(P<.001)。
  • 调整潜在混杂因素后,心脏干预患者接受EVT的几率更低(aOR 0.27;95%CI 0.23-0.31),调整NIHSS评分后结果一致(aOR 0.28;95%CI 0.22-0.35)。
  • 心脏干预患者中,接受EVT与出院回家几率升高2倍以上相关(aOR 2.21;95%CI 1.14-4.29)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Ischemic stroke is a serious complication of cardiac intervention, including surgery and percutaneous procedures. Endovascular thrombectomy (EVT) is an effective treatment for ischemic stroke and may be particularly important for cardiac intervention patients who often cannot receive intravenous thrombolysis. OBJECTIVE: To examine trends in EVT for ischemic stroke during hospitalization of patients with cardiac interventions vs those without in the United States. DESIGN, SETTING, AND PARTICIPANTS: This cohort study involved a retrospective analysis using data for 4888 US hospitals from the 2016-2020 National Inpatient Sample database. Participants included adults (age ≥18 years) with ischemic stroke (per codes from the International Statistical Classification of Diseases, Tenth Revision, Clinical Modification), who were organized into study groups of hospitalized patients with cardiac interventions vs without. Individuals were excluded from the study if they had either procedure prior to admission, EVT prior to cardiac intervention, EVT more than 3 days after admission or cardiac intervention, or endocarditis. Data were analyzed from April 2023 to October 2023. EXPOSURES: Cardiac intervention during admission. MAIN OUTCOMES AND MEASURES: The odds of undergoing EVT by cardiac intervention status were calculated using multivariable logistic regression. Adjustments were made for stroke severity in the subgroup of patients who had a National Institutes of Health Stroke Scale (NIHSS) score documented. As a secondary outcome, the odds of discharge home by EVT status after cardiac intervention were modeled. RESULTS: Among 634 407 hospitalizations, the mean (SD) age of the patients was 69.8 (14.1) years, 318 363 patients (50.2%) were male, and 316 044 (49.8%) were female. A total of 12 093 had a cardiac intervention. An NIHSS score was reported in 218 576 admissions, 216 035 (34.7%) without cardiac intervention and 2541 (21.0%) with cardiac intervention (P < .001). EVT was performed in 23 660 patients (3.8%) without cardiac intervention vs 194 (1.6%) of those with cardiac intervention (P < .001). After adjustment for potential confounders, EVT was less likely to be performed in stroke patients with cardiac intervention vs those without (adjusted odds ratio [aOR], 0.27; 95% CI, 0.23-0.31), which remained consistent after adjusting for NIHSS score (aOR, 0.28; 95% CI, 0.22-0.35). Among individuals with a cardiac intervention, receiving EVT was associated with a 2-fold higher chance of discharge home (aOR, 2.21; 95% CI, 1.14-4.29). CONCLUSIONS AND RELEVANCE: In this study, patients hospitalized with ischemic stroke and cardiac intervention may be less than half as likely to receive EVT as those without cardiac intervention. Given the known benefit of EVT, there is a need to better understand the reasons for lower rates of EVT in this patient population.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. de Havenon A, Zhou LW, Koo AB, et al. Endovascular Treatment of Acute Ischemic Stroke After Cardiac Interventions in the United States. JAMA Neurol. 2024. PMID: 38285452. doi:10.1001/jamaneurol.2023.5416

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。